Literature DB >> 4456977

Haemodynamic effects of dihydroergotamine in patients with postural hypotension.

S Bevegård, J Castenfors, L E Lindblad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4456977     DOI: 10.1111/j.0954-6820.1974.tb01044.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  6 in total

1.  Treatment of orthostatic hypotension with dihydroergotamine.

Authors:  G Jennings; M Esler; R Holmes
Journal:  Br Med J       Date:  1979-08-04

Review 2.  Treatment of postural hypotension. A review.

Authors:  R A Ahmad; R D Watson
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  Bioavailability of dihydroergotamine in man.

Authors:  P J Little; G L Jennings; H Skews; A Bobik
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  Effects of dihydroergotamine (DHE) on blood flow and metabolism in the underperfused myocardium in anaesthetized dogs.

Authors:  R Seitelberger; W Schütz; G Raberger
Journal:  Basic Res Cardiol       Date:  1984 Jul-Aug       Impact factor: 17.165

Review 5.  Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.

Authors:  Cyndya A Shibao; Horacio Kaufmann
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

6.  Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure.

Authors:  Amy C Arnold; Claudia E Ramirez; Leena Choi; Luis E Okamoto; Alfredo Gamboa; André Diedrich; Satish R Raj; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  Front Physiol       Date:  2014-07-24       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.